Tetrazole derivatives
US-2024382468-A2 · Nov 21, 2024 · US
Gastric reflux resistant dosage forms
US9192582B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9192582-B2 |
| Application number | US-201414507327-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 6, 2014 |
| Priority date | Dec 22, 2005 |
| Publication date | Nov 24, 2015 |
| Grant date | Nov 24, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Gastric resistant film-forming compositions are described herein. The composition comprises a gastric resistant natural polymer, a film-forming natural polymer, and optionally a gelling agent. Suitable gastric resistant natural polymers include polysaccharides such as pectin and pectin-like polymers. The film-forming composition can be used to prepare soft or hard shell gelatin capsules which can encapsulate a liquid or semi-solid fill material or a solid tablet (Softlet®) comprising an active agent and one or more pharmaceutically acceptable excipients. Alternatively, the composition can be administered as a liquid with an active agent dissolved or dispersed in the composition. The compositions are not only gastric resistant but may also prevent gastric reflux associated with odor causing liquids, such as fish oil or garlic oil, encapsulated in a unit dosage form and esophageal irritation due to the reflux of irritant drugs delivered orally.
First claim
Opening claim text (preview).
I claim: 1. An oral gastric resistant soft capsule shell, prepared by a process comprising: A) preparing a mixture comprising (a) pectin in an amount from 2% to less than 5% by weight; (b) gelatin in an amount from 25% to 40% by weight; (c) glycerol in an amount from 8% to 30% by weight; (d) a divalent cation selected from the group consisting of calcium salts, magnesium salts, and calcium gelatin in an amount from 1% to 2% by weight; and (e) water; B) casting the gel…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
- A61K9/4825Primary
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9192582B2 cover?
- Gastric resistant film-forming compositions are described herein. The composition comprises a gastric resistant natural polymer, a film-forming natural polymer, and optionally a gelling agent. Suitable gastric resistant natural polymers include polysaccharides such as pectin and pectin-like polymers. The film-forming composition can be used to prepare soft or hard shell gelatin capsules which c…
- Who is the assignee on this patent?
- Banner Pharmacaps Inc, Banner Life Sciences Llc
- What technology area does this patent fall under?
- Primary CPC classification A61K9/4825. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Nov 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).